Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/1996
05/29/1996CN1123275A Substituted chinolin derivative, preparation and application of same
05/29/1996CN1123144A 3-substituted-2-oxindoles as inhibitors of viral replication
05/28/1996US5521310 Process to obtain benzoxazines to be used for the synthesis of ofloxazine, levofloxazine and derivatives
05/28/1996US5521308 Process for the preparation of crystalline TACA
05/28/1996US5521307 Methods and compounds for the preparation of carbacephems
05/28/1996US5521219 Treatment of aids
05/28/1996US5521194 Antiproliferative agent for restenosis treatment
05/28/1996US5521155 Antibiotic active against grampositive bacteria
05/28/1996US5521082 Solvent extraction, precipitation, gel filtration, ion exchanging, vaccines
05/28/1996US5521072 Vaccines
05/28/1996US5520920 Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions
05/28/1996CA2072573C Treatment of human retroviral infections with 2',3'-dideoxyinosine
05/23/1996WO1996015247A1 Purified papillomavirus proteins
05/23/1996WO1996015241A2 A polynucleotide tuberculosis vaccine
05/23/1996WO1996015238A1 Targeted t lymphocytes
05/23/1996WO1996015234A2 Lipid-splitting enzyme
05/23/1996WO1996015143A1 SYNTHESIS OF PEPTIDE NUCLEIC ACIDS (PNAs) AND ANALOGUES VIA SUBMONOMER APPROACH
05/23/1996WO1996015131A1 Macrocyclic lactone compounds and their production process
05/23/1996WO1996015130A1 Bicyclic oxazine and thiazine oxazolidinone antibacterials
05/23/1996WO1996014877A1 Novel tumor suppressor gene, hic-1
05/23/1996WO1996014876A1 Yeast-based delivery vehicles
05/23/1996WO1996014863A1 Suppression of proteolytic activity by dysfunctional protease formation
05/23/1996WO1996014860A1 Process for identifying para cation channel modulators
05/23/1996WO1996014847A1 Use of phosphonoacetic or-formic acids against human herpes virus -7 (hhv-7)
05/23/1996WO1996014831A1 Adjuvant for a vaccine composition
05/23/1996WO1996014737A1 Treating red blood cell solutions with anti-viral agents
05/23/1996WO1996012020A3 Hemoglobin receptors from neisseriae
05/23/1996WO1996010580A3 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines
05/23/1996CA2205414A1 Novel tumor suppressor gene, hic-1
05/23/1996CA2204908A1 Lipid cleavage enzyme
05/23/1996CA2204597A1 Suppression of proteolytic activity by dysfunctional protease formation
05/23/1996CA2203934A1 Targeted t lymphocytes
05/23/1996CA2203565A1 Synthesis of peptide nucleic acids (pnas) and analogues via submonomer approach
05/22/1996EP0712936A1 Low-molecular dna from sturgeon mult, a method of obtaining the dna and a pharmaceutical preparation based on it
05/22/1996EP0712926A2 Fish pancreatic disease virus
05/22/1996EP0712631A2 Cyclosporin containing multiple emulsions
05/22/1996EP0712405A1 Derivatives of monic acids a and c having antibacterial, antimycoplasmatical, antifungal and herbicidal activity
05/22/1996EP0677056B1 Oligonucleotide alkylphosphonates and alkylphosphonothioates
05/22/1996EP0521914B1 A method for regulating neuron development and maintenance
05/22/1996CN1122804A 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
05/22/1996CN1122803A Benzoxazolyl- and benzothiazolyloxazolidinones
05/22/1996CN1031825C Process for preparing heteroaroyl derivatives of monocyclic beta-lactam antibiotics
05/21/1996US5519126 Combatting diseases by biochemicl intervention at the rna and dna level
05/21/1996US5519115 Reverse antimicrobial peptides
05/21/1996US5519114 Retroviral superantigens, superantigen peptides, and methods of use
05/21/1996US5519056 Fungicides against candida or aspergillus
05/21/1996US5519028 Antiviral preparations
05/21/1996US5519016 Aryl group- or aromatic heterocyclic group-substituted aminoquinolone derivatives and anti-HIV agent
05/21/1996US5519015 Bactericides
05/21/1996US5518723 Vaccines containing antibodies and epitopes
05/17/1996WO1996014418A1 Respiratory syncytial virus protein g expressed on bacterial membrane
05/17/1996WO1996014393A1 H. pylori fermentation process
05/17/1996WO1996014330A1 Amino acid nucleic acids
05/17/1996WO1996014329A1 Sugar modified nucleosides and their use for synthesis of oligonucleotides
05/17/1996WO1996014328A1 Tumor necrosis factor-gamma
05/17/1996WO1996014327A1 Antifungal sordaridin derivatives
05/17/1996WO1996014326A1 Antifungal sordaridin derivatives
05/17/1996WO1996014314A2 Thiepane compounds inhibiting and detecting hiv protease
05/17/1996WO1996014088A1 Attenuated canine parvovirus vaccine
05/17/1996WO1996014073A1 Treatment of urogenital cancer with boron neutron capture therapy
05/17/1996WO1996014065A1 Therapeutic quassinoid preparations with antineoplastic, antiviral, and herbistatic activity
05/17/1996WO1996010419A3 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule
05/17/1996WO1996007392A3 Oligonucleotide prodrugs
05/17/1996CA2689871A1 Combined meningitis vaccine
05/17/1996CA2307311A1 Sugar modified nucleosides and their use for synthesis of oligonucleotides
05/17/1996CA2204618A1 Respiratory syncytial virus protein g expressed on bacterial membrane
05/17/1996CA2204361A1 Therapeutic quassinoid preparations with antineoplastic, antiviral, and herbistatic activity
05/17/1996CA2204276A1 H. pylori fermentation process
05/17/1996CA2203570A1 Thiepane compounds inhibiting and detecting hiv protease
05/17/1996CA2202274A1 Amino acid nucleic acids
05/17/1996CA2179403A1 Antifungal sordaridin derivatives
05/15/1996EP0711829A2 Recombinant alphavirus vectors
05/15/1996EP0711785A1 Novel antitumor antibiotic compounds: hayumicins and analogs thereof
05/15/1996EP0711783A1 Antifungal Sordarin derivatives
05/15/1996EP0711774A1 Crystalline cephem-addition salts and process for their preparation
05/15/1996EP0711771A2 Substituted-1,3-oxathiolanes with antiviral properties
05/15/1996EP0711563A1 Novel Borrelia vaccine
05/15/1996EP0711557A1 Base for formulating pharmaceutical agents
05/15/1996EP0711556A1 Intravenous solutions containing staurosporine derivatives
05/15/1996EP0711555A2 Enzyme inactivators
05/15/1996EP0711350A1 Clavulanic acid dehydrogenase, preparation and use for the production of clavulanic acid
05/15/1996EP0711340A1 High yielding influenza viruses
05/15/1996EP0711310A1 Human antibodies against varicella-zoster virus
05/15/1996EP0711307A1 Peptides for neutralizing the toxicity of lipid a
05/15/1996EP0711305A1 Protegrins
05/15/1996EP0711301A1 Processes and intermediates for phosphorous-containing covalent linkages
05/15/1996EP0711297A1 Rapamycin derivative with antimicrobial, anticancer and immunomodulation activity
05/15/1996EP0711282A1 Compounds as pde iv and tnf inhibitors
05/15/1996EP0711275A1 (thio)carbimidinic acid derivatives and medicaments containing the same
05/15/1996EP0711170A1 T-lymphocyte-containing pharmaceutical composition for treating infections
05/15/1996EP0711168A1 Methods of treating apoptosis and associated conditions
05/15/1996EP0711165A1 Use of quinoline-3-carboxamide compounds for inhibiting the production of tumour necrosis factor (tnf) and/or for the treatment of septic shock
05/15/1996EP0711163A1 Use of benzydamine in the treatment of pathological conditions caused by tnf
05/15/1996EP0711160A1 Method of inhibiting the replication of human immunodeficiency viruses with substituted azaspiranes
05/15/1996EP0711140A1 Antifungal nail solution
05/15/1996EP0679153A4 Amino acids and peptides having modified terminals.
05/15/1996EP0563389B1 Pharmaceutical aerosol preparation and its use for treatment and prophylaxis of viral diseases
05/15/1996EP0465565B1 Treatment of aids dementia, myelopathy and blindness
05/15/1996CN1122600A Second messenger cell signaling inhibitors
05/15/1996CN1122576A Therapeutic strategies for immunoinfective cluster virus infections